These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined use of ultraviolet irradiation and beta propiolactone sterilization of sera infected with a virus. SMOLENS J; STOKES J Proc Soc Exp Biol Med; 1954 Jul; 86(3):538-9. PubMed ID: 13194713 [No Abstract] [Full Text] [Related]
4. [Antigenic and vaccinating power of Newcastle virus inactivated by beta-propiolactone]. LEPINE P; ATANASIU P Ann Inst Pasteur (Paris); 1956 Jul; 91(1):100-2. PubMed ID: 13340335 [No Abstract] [Full Text] [Related]
5. Effect of beta-propiolactone on complement-fixing antigens of St. Louis encephalitis virus. FINKELSTEIN RA; SULKIN SE Proc Soc Exp Biol Med; 1957 May; 95(1):112-5. PubMed ID: 13432007 [No Abstract] [Full Text] [Related]
6. The sterilization of human arterial homografts with beta-propiolactone; experimental and clinical observations. SZILAGYI DE; OVERHULSE PR; SHONNARD CP; LOGRIPPO GA Surg Forum; 1955; 5():244-52. PubMed ID: 13247029 [No Abstract] [Full Text] [Related]
7. Betapropiolactone vapor as a disinfectant. HOFFMAN RK; WARSHOWSKY B Appl Microbiol; 1958 Sep; 6(5):358-62. PubMed ID: 13571980 [No Abstract] [Full Text] [Related]
8. [Uses for -propiolactone]. Künzel W; Zillgith E Pharmazie; 1973 Mar; 28(3):205-7. PubMed ID: 4573487 [No Abstract] [Full Text] [Related]
9. The effects of beta-propiolactone on the metabolism of Candida albicans. GALE GR J Infect Dis; 1955; 96(3):250-8. PubMed ID: 14392370 [No Abstract] [Full Text] [Related]
10. Management of an artery-graft bank; with special reference to sterilisation by beta-propiolactone. BARSON GJ; CRAWFORD N; RAINS AJ; SHARPE SH; SHREWSBURY JF Lancet; 1956 Oct; 271(6947):830-2. PubMed ID: 13368532 [No Abstract] [Full Text] [Related]
11. The inhibition of respiration of certain dermatophytes by beta propiolactone. GALE GR J Invest Dermatol; 1954 Jan; 22(1):1-3. PubMed ID: 13118247 [No Abstract] [Full Text] [Related]
12. [Inactivation and antigenicity of poliomyelitis virus type 2 (MEF-1 strain) treated with beta-propiolactone]. D'ALESSANDRO G; ODDO FG; INSERILLO G Riv Ist Sieroter Ital; 1956; 31(1):65-8. PubMed ID: 13337026 [No Abstract] [Full Text] [Related]
13. Method for disinfecting large enclosures with beta-propiolactone vapor. SPINER DR; HOFFMAN RK Appl Microbiol; 1960 May; 8(3):152-5. PubMed ID: 13833363 [No Abstract] [Full Text] [Related]
14. The effect of beta-propiolactone on bacterial spores. CURRAN HR; EVANS FR J Infect Dis; 1956; 99(3):212-8. PubMed ID: 13376916 [No Abstract] [Full Text] [Related]
15. The carcinogenicity of beta-propiolactone for mouseskin. GLENDENNING OM; ROE FJ Br J Cancer; 1956 Jun; 10(2):357-62. PubMed ID: 13364127 [No Abstract] [Full Text] [Related]
17. Further studies on incomplete carcinogenesis: triethylene melamine (T.E.M.), 1,2-benzanthracene and beta-propiolactone, as initiators of skin tumour formation in the mouse. ROE FJ; SALAMAN MH Br J Cancer; 1955 Mar; 9(1):177-203. PubMed ID: 14378502 [No Abstract] [Full Text] [Related]
18. Effect of beta-propiolactone and beta-nitropropionic acid on rat brain monoamine oxidase. Mohammed YS; Mahfouz MM; Osman MY Biochem Pharmacol; 1977 Jan; 26(1):62-3. PubMed ID: 831726 [No Abstract] [Full Text] [Related]
19. The use of beta-propiolactone for the preparation of virus vaccines. II. Antigenicity. POLLEY JR; GUERIN MM Can J Microbiol; 1957 Oct; 3(6):871-7. PubMed ID: 13472512 [No Abstract] [Full Text] [Related]
20. [Use of beta-propiolactone for sterilization of apparatus used for microbial cultivation]. Shkidchenko AN; Malishevskaia LV Prikl Biokhim Mikrobiol; 1973; 9(1):130-3. PubMed ID: 4701619 [No Abstract] [Full Text] [Related] [Next] [New Search]